Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women

Maturitas

Volumn 45, Issue 3, 2003, Pages 205-212

  Castelo Branco, Camil ^b   Blumel J E ^a   Roncagliolo, M E ^a   Haya, J ^c   Bolf, D ^a   Binfa, L ^a   Tacla, X ^a   Colodron M ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

Author keywords

Cardiovascular risk factors; Hormone replacement therapy; Menopause

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGING; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; EVALUATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; PREVALENCE; SITTING; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0038344704     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00140-3     Document Type: Article

References (41)

1. Instituto Nacional de Estadísticas. Demografía. República de Chile. Ed INE, 1998.
2. Instituto Nacional de Estadísticas. Los Adultos Mayores en Chile, Enfoques Estadísticos 1999;4:1-4.
3. National Institutes of Health. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. The Sixth Report of The Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. NIH Publication No. 98-4080, 1997.
4. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
5. Bush T.L. Preserving cardiovascular benefits of hormone replacement therapy. J. Reprod. Med. 45:(3 Suppl.):2000;259-273.
6. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
7. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., Hsia J., Hulley S., Herd A., Khan S., Newby L.K., Waters D., Vittinghoff E., Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). J. Am. Med. Assoc. 288:2002;49-57.
8. Blumel J.E., Roncagliolo M.E., Brandt A., Tacla X., Gramegna G. Prevalencia de factores de riesgo cardiovascular en mujeres. Cambios asociados con la edad, la menopausia y la terapia estrogénica. Rev. Soc. Argentina Nutrición. 5:(1):1994;7-12.
9. Berrios X., Jadué L., Zenteno J., Ross M.I., Rodriguez H. Prevalencia de los factores de Riesgo de Enfermedades Crónicas. Rev. Med. de Chile. 118:1990;597-604.
10. US Department of Health and Human Services. Public Health Service. National Institutes of Health. The Sixth Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 98-4080, 1997.
11. World Health Organization. Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. WHO/NCD/NCS/99.2. 1999. Geneva.
12. US Department of Health and Human Services. Public Health Service. National Institutes of Health. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) del National Cholesterol Education Program NIH Publication No. 93-3096, 1993.
13. US Department of Health and Human Services. Public Health Service. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in adults. NIH Publication No. 98-4083, 1998.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Borghi C., Veronesi M., Prandin M.G., Dormi A., Ambrosioni E. Statins and blood pressure regulation. Curr. Hypertens. Rep. 3:2001;281-288.
16. Wolf P.H., Modans J.H., Finucane F.F., Higgins M., Kleinman J.C. Reduction of cardiovascular disease related mortality among postmenopausal women who use hormones. Am. J. Obstet. Gynecol. 164:(2):1991;489-494.
17. Manson J.E., Spelsberg A. Risk modification in the diabetic patient. Manson J.E., Ridker P.M., Gaziano J.M., Hennekens C.H. Prevention of myocardial infarction. 1996;241-273 Oxford University Press, New York, NY.
18. Stamler J., Daviglus M.L., Garside D.B., Dyer A.R., Greenland P., Neaton J.D. Relationship of baseline serum cholesterol levels in three large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J. Am. Med. Assoc. 284:(3):2000;311-318.
19. Manolio T.A., Pearson T.A., Wenger N.K., Barrett-Connor E., Payne G.H., Harlan W.R. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann. Epidemiol. 2:1992;161-176.
20. Albala C., Vio F., Kain J. Obesidad: un desafío pendiente en Chile. Rev. Med. Chile. 126:(8):1998;1001-1009.
21. Losonczy K.G., Harris T.B., Cornoni-Huntley J., Simonsick E.M., Wallace R.B., Cook N.R., Ostfeld A.M., Blazer D.G. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age. Am. J. Epidemiol. 141:(4):1995;312-321.
22. Mensink G.B., Deketh M., Mul M.D., Schuit A.J., Hoffmeister H. Physical activity and its association with cardiovascular risk factors and mortality. Epidemiology. 7:(4):1996;391-397.
23. Jadué L., Vega J., Escobar M.C., Delgado I., Garrido C., et al. Factores de riesgo para las enfermedades no transmisibles: metodología y resultados globales de la encuesta de base del programa CARMEN. Rev. Med. de Chile. 127:(8):1999;1004-1013.
24. Dunn A.L., Marcus B.H., Kampert J.B., Garcia M.E., Kohl H.W. III, Blair S.N. Reduction in cardiovascular disease risk factors: 6-month results from Project Active. Prev. Med. 26:(6):1997;883-892.
25. Peters H.W., Westendorp I.C., Hak A.E., Grobbee D.E., Stehouwer C.D., Hofman A., Witteman J.C. Menopausal status and risk factors for cardiovascular disease. J. Intern. Med. 246:(6):1999;521-528.
26. Schaefer E.J., Lamon-Fava S., Cohn S.D., Schaefer M.M., Ordovas J.M., Castelli W.P., Wilson P.W. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 35:(5):1994;779-792.
27. Castelo-Branco C., Casals E., Sanllehy C., González-Merlo J., Iglesias X. Effect of oophorectomy and hormone replacement therapy on plasma lipids. Maturitas. 17:1993;113-122.
28. Castelo-Branco C., Casals E., Figueras F., Sanjuán A., Vicente J.J., Balasch J., Vanrell J.A. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B. Menopause. 6:(2):1999;92-97.
29. Do K.A., Green A., Guthrie J.R., Dudley E.C., Burger H.G., Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am. J. Epidemiol. 151:(6):2000;584-593.
30. Shelley J.M., Green A., Smith A.M., Dudley E., Dennerstein L., Hopper J., Burger H. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann. Epidemiol. 8:(1):1998;39-45.
31. Casiglia E., Ginocchio G., Tikhonoff V., D'Este D., Mazza A., et al. Blood pressure and metabolic profile after surgical menopause: comparison with fertile and naturally-menopausal women. J. Hum. Hypertens. 14:2000;799-805.
32. Smith M.H., Anderson R.T., Bradham D.D., Longino C.F. Jr. Rural and urban differences in mortality among Americans 55 years and older: analysis of the National Longitudinal Mortality Study. J. Rural Health. 11:1995;274-285.
33. Acs N., Vajo Z., Miklos Z., Siklosi G., Paulin F., Szekacs B. Postmenopausal hormone replacement therapy and cardiovascular mortality in Central-Eastern Europe. J. Gerontol. 55:2000;M160-M162.
34. Castelo-Branco C., Vicente J.J., Figueras F., Sanjuán A., Martínez de Osaba M.J., Casals E., Pons F., Balasch J., Vanrell J.A. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas. 34:2000;161-168.
35. Castelo-Branco C., Casals E., Sanllehy C., Durán M., Fortuny A., Vanrell J.A. Effects of progestogen on lipids, lipoproteins, and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. J. Reprod. Med. 41:1996;833-838.
36. Wing R.R., Matthews K.A., Kuller L.H., Meilahn E.N. Weight gain at the time of menopause. Arch. Intern. Med. 151:(1):1991;97-102.
37. Tchernof A., Poehlman E.T. Effects of the menopause transition on body fatness and body fat distribution. Obes. Res. 6:(3):1998;246-254.
38. Lip G.Y., Beevers M., Churchill D., Beevers D.G. Hormone replacement therapy and blood pressure in hypertensive women. J. Hum. Hypertens. 8:(7):1994;491-494.
39. Oparil S. Hypertension in postmenopausal women: pathophysiology and management. Curr. Opin. Nephrol. Hypertens. 4:(5):1995;438-442.
40. Lip G., Beevers M., Churchill D., Beevers D.G. Do clinicians prescribe HRT for hypertensive postmenopausal women. Br. J. Clin. Pract. 49:(2):1995;61-64.
41. Szekacs B., Vajo Z., Acs N., Hada P., Csuzi L., Bezeredi J., Magyar Z., Brinton E.A. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension. Menopause. 7:(1):2000;31-35.